RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Perspective: Demystifying CMC Regulatory Strategy for Biologics, Part 2: Biologics Are Not Chemical

Perspective: Demystifying CMC Regulatory Strategy for Biologics, Part 2: Biologics Are Not Chemical Drugs

Posted 01 November 2011 | By John Geigert, PhD, RAC

Senior managers, especially if they have recently moved from the chemical drug side of the business into biologics, may raise the question of whether biologics are really different from chemical drugs or if this is just a perception. As clearly stated by the regulatory authorities, biologics are not chemical drugs and similar biologics are not biogenerics.

 

© 2022 Regulatory Affairs Professionals Society.